Buprenorphine And Naloxone Film, Soluble
Product Images NDC 43598-581

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 43598-581). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddys Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Packaging label for Buprenorphine and Naloxone Sublingual Film 4 mg/1 mg by Dr. Reddy's Laboratories Inc. The label indicates it is a prescription drug in film form for sublingual use. The package contains 30 pouches, each with one sublingual film. Important warnings and dosage instructions are also present.*

FDA Label Image

Carton2 (Carton2)

Packaging label for Buprenorphine and Naloxone Sublingual Film 12 mg/3 mg by Dr.Reddys Laboratories Inc. The label shows that the product is for prescription use only, supplied in 30 pouches each containing one sublingual film. It includes instructions and warnings, a barcode, lot and expiration date fields, and states the dosage form as buccal/sublingual film.*

FDA Label Image

Figure1 (Figure1)

An illustration showing hands peeling or unfolding a small medication label or leaflet, which contains a barcode and text, likely instructions or information for Buprenorphine and Naloxone soluble film dosage form by Dr. Reddys Laboratories Inc.*

FDA Label Image

Figure2 (Figure2)

An instructional illustration showing hands opening the packaging and using scissors to cut a single dose of buprenorphine and naloxone soluble film, highlighting prepared administration steps for the sublingual or buccal route.*

FDA Label Image

Figure3 (Figure3)

An illustration showing the placement of a soluble buccal or sublingual film of Buprenorphine and Naloxone inside an open mouth, positioned on the cheek or under the tongue for absorption.*

FDA Label Image

Figure4 (Figure4)

Illustrations showing the administration of Buprenorphine and Naloxone soluble film. One image depicts placing the film inside the lower cheek (buccal), and the other shows the film positioned under the tongue (sublingual) for dissolution.*

FDA Label Image

Pouch1 (Pouch1)

Label for Buprenorphine and Naloxone Sublingual Film 4 mg/1 mg in a single sublingual film unit dose. The label shows the proprietary and generic names, dosage form, strength, and restriction to prescription use only. It is labeled by Dr. Reddys Laboratories Inc. Additional text includes warnings for accidental ingestion by children and instructions not to cut, chew, or swallow the film.*

FDA Label Image

Pouch2 (Pouch2)

Label for Buprenorphine and Naloxone Sublingual Film, 12 mg/3 mg strength, manufactured by Dr.Reddys Laboratories Inc. The label indicates one sublingual film with instructions for use and safety warnings, including keeping the film out of reach of children. The label also displays the NDC 43598-581-01 and includes a QR code and bar code.*

FDA Label Image

Structure1 (Structure1)

Chemical structure of Buprenorphine hydrochloride is shown, including the molecular formula C29H41NO4·HCl and molecular weight 504.10.*

FDA Label Image

Structure2 (Structure2)

Chemical structure diagram of Buprenorphine hydrochloride dihydrate, showing its molecular formula C19H21NO4, with hydrochloride and water components (HCl and 2H2O), and molecular weight 399.87.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.